167 related articles for article (PubMed ID: 38409491)
1. Evaluation of Type 2 SLE symptoms in patients with a range of lupus nephritis activity.
Rogers JL; Clowse MEB; Pisetsky DS; Criscione-Schreiber LG; Sun K; Sadun RE; Maheswaranathan M; Burshell DR; Doss J; Eudy AM
Clin Rheumatol; 2024 Apr; 43(4):1319-1326. PubMed ID: 38409491
[TBL] [Abstract][Full Text] [Related]
2. The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity.
Eudy AM; Reeve BB; Coles T; Lin L; Rogers JL; Pisetsky DS; Criscione-Schreiber LG; Doss J; Sadun R; Sun K; Clowse ME
Lupus; 2022 May; 31(6):697-705. PubMed ID: 35343853
[TBL] [Abstract][Full Text] [Related]
3. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
Lewandowski LB; Schanberg LE; Thielman N; Phuti A; Kalla AA; Okpechi I; Nourse P; Gajjar P; Faller G; Ambaram P; Reuter H; Spittal G; Scott C
Lupus; 2017 Feb; 26(2):186-194. PubMed ID: 27488473
[TBL] [Abstract][Full Text] [Related]
4. Disease-specific quality of life in patients with lupus nephritis.
Jolly M; Toloza S; Goker B; Clarke AE; Navarra SV; Wallace D; Weisman M; Mok CC
Lupus; 2018 Feb; 27(2):257-264. PubMed ID: 28728507
[TBL] [Abstract][Full Text] [Related]
5. Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry.
Kim SK; Choe JY; Lee SS
Yonsei Med J; 2018 Sep; 59(7):857-864. PubMed ID: 30091319
[TBL] [Abstract][Full Text] [Related]
6. Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes.
Rogers JL; Eudy AM; Pisetsky D; Criscione-Schreiber LG; Sun K; Doss J; Clowse MEB
Arthritis Care Res (Hoboken); 2021 Mar; 73(3):386-393. PubMed ID: 31909888
[TBL] [Abstract][Full Text] [Related]
7. Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).
Chaigne B; Chizzolini C; Perneger T; Trendelenburg M; Huynh-Do U; Dayer E; Stoll T; von Kempis J; Ribi C;
BMC Immunol; 2017 Mar; 18(1):17. PubMed ID: 28351341
[TBL] [Abstract][Full Text] [Related]
8. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort.
Inês L; Silva C; Galindo M; López-Longo FJ; Terroso G; Romão VC; Rúa-Figueroa I; Santos MJ; Pego-Reigosa JM; Nero P; Cerqueira M; Duarte C; Miranda LC; Bernardes M; Gonçalves MJ; Mouriño-Rodriguez C; Araújo F; Raposo A; Barcelos A; Couto M; Abreu P; Otón-Sanchez T; Macieira C; Ramos F; Branco JC; Silva JA; Canhão H; Calvo-Alén J; ;
Arthritis Care Res (Hoboken); 2015 Aug; 67(8):1180-5. PubMed ID: 25581417
[TBL] [Abstract][Full Text] [Related]
9. Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus.
Elefante E; Tani C; Stagnaro C; Ferro F; Parma A; Carli L; Signorini V; Zucchi D; Peta U; Santoni A; Raffaelli L; Mosca M
RMD Open; 2020 Feb; 6(1):. PubMed ID: 32075876
[TBL] [Abstract][Full Text] [Related]
10. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
11. Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis.
Ebaid AM; Ezzeldin N; Abdelhady EI; Mohammed HA; Abdallah AL
Lupus; 2023 Jan; 32(1):101-110. PubMed ID: 36418233
[TBL] [Abstract][Full Text] [Related]
12. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.
Gómez-Puerta JA; Ortiz-Reyes B; Urrego T; Vanegas-García AL; Muñoz CH; González LA; Cervera R; Vásquez G
Lupus; 2018 Apr; 27(4):637-646. PubMed ID: 29073812
[TBL] [Abstract][Full Text] [Related]
13. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.
Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E
Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821
[TBL] [Abstract][Full Text] [Related]
14. Risk of Renal Failure Within 10 or 20 Years of Systemic Lupus Erythematosus Diagnosis.
Petri M; Barr E; Magder LS
J Rheumatol; 2021 Feb; 48(2):222-227. PubMed ID: 32295853
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life, fatigue and health utilities in lupus nephritis: A systematic literature review.
Kharawala S; Kaur G; Shukla H; Scott DA; Hawkins N; Chen WH; Gairy K
Lupus; 2022 Aug; 31(9):1029-1044. PubMed ID: 35607279
[TBL] [Abstract][Full Text] [Related]
16. Comparing the 1997 update of the 1982 American College of Rheumatology (ACR-97) and the 2012 Systemic Lupus International Collaborating Clinics (SLICC-12) criteria for systemic lupus erythematosus (SLE) classification: which enables earlier classification of SLE in an urban Asian population?
Low ESH; Krishnaswamy G; Thumboo J
Lupus; 2019 Jan; 28(1):11-18. PubMed ID: 30463470
[TBL] [Abstract][Full Text] [Related]
17. The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis.
Rizk A; Gheita TA; Nassef S; Abdallah A
Int J Rheum Dis; 2012 Jun; 15(3):261-7. PubMed ID: 22212605
[TBL] [Abstract][Full Text] [Related]
18. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
[TBL] [Abstract][Full Text] [Related]
19. Short-term Accrual 2019 European League Against Rheumatism/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage in Lupus Patients With and Without Nephritis at Disease Onset.
Munhoz GA; Aikawa NE; Silva CA; Pasoto SG; Pedrosa TN; Seguro LPC; Bonfa E; Borba EF
J Clin Rheumatol; 2023 Jun; 29(4):190-195. PubMed ID: 36683233
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
